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ABSTRACT OF THESIS

NUTRIENT AND MEDICATION INTAKE OF CHILDREN WITH
NEURODEVELOPMENTAL DISORDERS
The incidence of autism continues to rise with no cure or understanding of the cause
of the disorder. Approximately one in 150 children will be diagnosed with an (ASD)
Autism Spectrum Disorder although recent prevalence data suggest one in 91. The
objective of the study is to assess medicinal intake regarding prescription and
nonprescription medications of children with Autism Spectrum Disorders and its
affect on their nutritional status compared to age, and sex matched healthy children.
The study included families of children with autism in which they completed
questionnaires and 24‐hour recalls. There were 26 children used within the
questionnaire and 13 were utilized in the 24‐hour recall, ranging in age from 2‐11.
Results demonstrated that children with autism were not deficient in relation to
vital nutrients needed for neurological function. Prescription and nonprescription
medications also did not pose many side effects; however, there was slight weight
gain in their utilization. Information from the assessments of the child’s nutritional
needs and drug nutrient interaction will allow parents, paraprofessionals and
healthcare professionals to provide education to families.
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Chapter 1: Introduction
First described in the scientific literature in 1943 by Dr. Leo Kanner, autism
was reported in relation to a child’s inability to relate themselves to their
surroundings. The American Psychiatric Association describes autism as a
neurodevelopmental disorder with characteristics of impaired reciprocal social
interaction, impaired verbal and nonverbal communication, and appearance of
repetitive stereotypic activities, behaviors, and interests, which can range from mild
to disabling (1). Autism usually begins during infancy, at the latest, in the first three
years of life. Because of its links to genetics and neural development and the
abnormalities related to social interaction, autism offers a vast array of
opportunities for health professionals and beyond to study (2).
The hallmark feature of children with autism includes impaired social
interaction. Parents are usually the first to recognize the symptoms. As early as
infancy, a baby with autism may be unresponsive to people or focus on one item for
long periods. They may fail to respond to their name and avoid eye contact. They
have the tendency to misunderstand social cues, such as facial expressions or tone
of voice. Many children with autism have a reduced sensitivity to pain; however,
they are abnormally sensitive to touch, sound, or other stimulation involving the
senses (3).
Children with autism tend to have an oral motor deficit, which affects the
musculature of the mouth. This includes the jaw, lips, as well as the tongue. The
causes of oral motor disorders include incorrect motor programming. This happens
1

when the brain sends a message to the muscles of the mouth, but the muscles do not
receive the message or it is misinterpreted causing the muscles to not move at all or
move incorrectly. The second is low muscle tone, where the muscles of the jaw, lip,
or tongue are weak. This can lead to difficulty drinking from a straw or frequent
spilling of liquids when drinking due to a weak lip (4) creating situations that are of
major concern to dietitians and nutritionists.
The weakness of muscles from the jaw, lip, or tongue can have an impact on
the ability to chew and swallow food. Weak musculature may also affect the ability
to remove food from silverware along with the prevention of losing food from the
mouth. Weak musculature can impact the gag reflex resulting in episodes of
choking, possibly leading to a child’s willingness to eat altogether, creating a feeding
disorder. When a child is faced with unsuccessful eating patterns due to choking,
gagging, or spending long amounts of time at the table, their motivation when eating
is reduced (4).
ASDs, similar to other neurodevelopmental disabilities are not “curable.”
Even though outcomes and characteristics change over time, most children with
ASDs will remain within the spectrum through adulthood and regardless of
intellectual function, will experience problems with employment, mental health,
independent living, and social relationships. Therefore, it is vital that goals are set
to minimize the core deficits, such as maximize independence and quality of life and
alleviate family distress. It is also noted that socialization should be promoted along
with educating family and friends regarding these goals (5).
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Autism is a common condition listed in a group of developmental disorders
also known as the autism spectrum disorders (ASDs). Within the autism spectrum
disorders are Asperger syndrome, Rett syndrome, childhood disintegrative
disorder, and pervasive developmental disorder‐not otherwise specified, referred to
as PDD‐NOS (3).
Autistic Disorder
The child has delays or abnormal functioning in social interaction, language, or
play by age three. As far as social interaction, in order to be diagnosed, a child must
meet at least two of the following characteristics described by the DSM IV (2):
•
•
•
•

Impairment in the use of nonverbal behaviors, such as eye‐to‐eye gaze
Failure to develop peer relationships
Lack of seeking to share enjoyment with others
Lack of social or emotional reciprocity

Pertaining to communication, at least one of the following will occur:
•
•
•
•

Delay in, or total lack of, spoken language
Inability to initiate or sustain a conversation with others
Repetitive use of language
Lack of make‐believe or imitative play

Behavior will manifest by one of the following:
•
•
•
•

Preoccupied with one or more patterns of interest
Adherence to nonfunctional rituals or routines
Repetitive motor mannerisms
Preoccupation with parts of objects

3

Asperger
There is no clinically significant delay in language, cognitive development, or
development of self‐help skills. Diagnosis regarding social interaction and behavior
are viewed the same as autistic disorder, however, there are no clinically significant
delays regarding language in the communication field.
Rett
There is normal prenatal development within this category and apparent
normal development for the first five months with a deceleration of head growth
between 5 and 48 months. Within the field of social interaction, there is a loss of
social engagement seen early in the course even though social interaction develops
later. At a communication level, the child has severely impaired expressive and
receptive language development along with severe psychomotor retardation.
Behaviorally, children with Rett’s Disorder have a loss of previously acquired hand
movements that serve purpose, along with poor coordinated gait or trunk
movements.
Childhood Disintegrative Disorder (CDD)
Normal development for at least the first two years of birth is seen with CDD
along with a significant loss of previously acquired skills before age ten. When
viewing social, communication, and behavior, the diagnosis of CDD coincides with
autistic disorder.
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Pervasive Developmental DisorderNot Otherwise Specified (PDDNOS)
This category of autism is used when pervasive impairment in social
interaction and communication along with the presence of stereotyped behaviors of
interest when criteria are not met for a specific disorder.
Therapies
No cure is available for children with autism; however, many therapies and
behavioral interventions have been designed to remedy specific behaviors. Health
professionals recommend that intervention should begin as early as possible. The
National Institute of Neurological Disorders and Stroke lists the following
interventions.
•

•

•

Educational/behavior interventions
o Highly structured and skill‐oriented training sessions to help
children develop language and social skills
o Includes family counseling for parents as well as siblings of children
with autism
Medications
o Doctors often prescribe antidepressant medication in an effort for
children with autism to handle symptoms of possible anxiety,
obsessive‐compulsive disorder, and even depression.
o Drugs typically used for treating children with attention deficit
disorder are sometimes used in an effort to decrease hyperactivity
and impulsivity
Other therapy
o Parents are told to use caution when considering other therapies not
recommended by their physician due to the lack of research
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Etiology
Etiology of autism remains unsolved. Current hypotheses include genetic
abnormalities (6), abnormal brain development (7), maternal and perinatal factors
(8), environmental insult (9) and a few others.
Prevalence of Autism
Prevalence is a measure used to identify a number of cases of a disease or
condition in a defined group of people over a defined period of time. Through
monitoring those with Autism Spectrum Disorders, it is possible to find out whether
the prevalence is increasing, decreasing, or demonstrating no change (10).
Due to the changing criteria when diagnosing children with autism, it has
presented to be a challenge in getting an accurate number, as one must consider
those on all aspects of the spectrum. Another issue when gathering data is that the
United States has not had a population‐based system to track the full ranges of ASDs
over time. Autism and related disorders are diagnosed through behavioral
observation of development, which makes describing the population even more
difficult, especially with changing criteria (10).
Currently, 1 in 150 children are diagnosed with autism. Although recent
studies put the rate at one in 91 (11), boys are four times more likely to be
diagnosed with autism than girls with 1 in 94 boys on the spectrum. Sixty‐seven
children are diagnosed each day with a new case diagnosed every 20 minutes. More
children will be diagnosed with autism this year than with AIDS, diabetes and
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cancer combined which makes autism the fastest growing developmental disability
in the United States (12).
An estimated economic cost associates autism with approximately 90 billion
dollars a year and is expected to double in the next decade. These costs include
education as well as treatment to help reduce the symptoms of the disorder.
Knowing the prevalence of ASDs can allow providers to plan for the funding and
resources. These may include therapy, trained teachers, health care providers, and
related service professionals. This knowledge can also raise awareness and educate
those with children who have been newly diagnosed (10).
Medicinal Impact
Of the many etiological theories regarding autism, nutrition and medication
use can play an active role in a child’s life. For example, a child with an iron
deficiency may have symptoms of irritability, reduced ability to learn, as well as a
short attention span. All of which are characteristics of a child with autism (13).
Data suggests that approximately 58 percent of patients with a diagnosis of
autism receive some type of pharmaceutical treatment. The use of age data suggests
that approximately 70 percent of children with autism spectrum disorders ranging
from 8 years old and up will receive some form of psychoactive medication in a
given year. Although there is no real medication treatment guideline regarding
autism spectrum disorders, the use of medications has substantially increased over
the years. Aman and others in 2005 reported large increases in medication use
from1993‐2001 (14). The drug class showing the largest increase was
7

antidepressants. Another study suggested that the most commonly prescribed
medications were 66 percent antipsychotics, 32 percent antidepressants and 17
percent stimulants (15).
Antipsychotics, the highest rated prescribed medication, had an increased
number of office visits within the United States by youth. This increase was
approximately 201,000 in 1993 to 1,224,000 in 2002. From 2000 to 2002, the
number of visits for antipsychotic treatment was significantly higher for male youth
than female youth as well as higher for white non‐Hispanic youth than for youth of
other racial or ethnic groups. The majority of diagnoses were disruptive behavior
disorders (37.8%), mood disorders (31.8%), pervasive developmental disorders or
mental retardation (17.3%), and psychotic disorders (14.2%) (16).
Almost all medications have side effects appearing to be endless with a
tendency to influence nutrition. In the use of atypical antipsychotics, such as
Clozaril, Zyprexa, Risperdal, Seroquel, Abilify, and Geodon, children are more prone
to weight gain. The most common side effects with antipsychotics include dry
mouth, photosensitivity, as well as constipation. The less common side effects
include diarrhea, nausea, headache, sleeplessness, and weakness. Many of these
side effects can affect a child with autism who is already impaired due to their
disorder (17) and interfere with nutritional status.
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Complementary and Alternative Medicine
Some parents resort to non‐traditional treatment options such as
complementary and alternative medicine (CAM) therapies. Examples of CAM that
impact nutrition status include therapeutic doses of vitamin, mineral or herbal
supplements, restrictive diet patterns, and non‐traditional medical procedures such
as chelation therapy.
Utilization of CAM often represents an attempt by parents to gain a sense of
control over their child’s chronic illness or disability and improve their child’s
quality of life (18). Actual benefits of these therapies are complicated to assess in a
research setting. Efficacy research studies regarding most CAM alternatives suffer
from difficulty in developing a placebo, inability to mask single or double blind, lack
of availability of valid outcome measures, and small treatment effects which require
long‐term trials with large numbers of patients (19).
Although national estimates indicate approximately 2% of all typical children
receive CAM (20), studies in children with autism indicate a much higher utilization
rate. Levy (21) and colleagues in 2003 indicate 31.7% of children with autism were
receiving some type of CAM therapy. Of these children, 16.9% were receiving a
biological treatment with no nutritional basis in theory (including vitamin
supplements), 15.5% were using a biological treatment with some nutritional basis
in theory (including a gluten and casein free diet or secretin administration), and
8.8% were using a nutritional treatment that had potentially harmful biological
implication (including chelation, and cod liver oil administration).
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Between 1990 and 1997, the estimated expenditure on CAM in the United
States increased by 45.2% to 21.2 million dollars and to 90 million dollars by 2001.
There are numerous views why parents are choosing to use CAM for their children
with autism. One reason for utilizing CAM may be that even though many
treatments, both conventional and unconventional, have been explored, there still is
not one single intervention that has been proven in eliminating the core symptoms
of ASD. In addition, families turn to CAM due to the fact that many children with
ASD do not have the access to treatments in their area (22).
Parents also have reported that they seek out CAM because they want more
emotional and physical comfort and feel that those who provide CAM have a more
hands‐on approach to care. Individuals feel that simpler and less invasive
approaches to treatment are important for the health and well‐being of their child.
The use of a more “natural” remedy rather than a “manufactured” or “artificial”
approach could prove to be more beneficial. These alternative therapies, such as
vitamin mega doses, do not require prescriptions, approvals from insurance,
constant visits to the doctor’s office or specialists, have lesser side effects and are
cost effective and easily accessible (22).
Internet use for Health Information
Computer literate patients are now more than ever seeking to take control of
their health through the use of the Internet in an effort to seek out information
related to illness and treatment. Despite the concerns regarding the integrity of the
health information, Americans are using the Web in retrieving information in an
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effort to gain knowledge in understanding and managing their diagnosis. The
National Telecommunications and Information Administration indicated that in the
year 2000, 44% of individuals had access to the Internet. This percentage increased
during the year 2002 to 54% and was projected to exceed 80% by the year 2005.
The number of Internet users within the United States is estimated to be between
122 million and 166 million. With this increase in Internet use, there is evidence
that it is increasing within certain populations such as the poor, the less educated,
the elderly, as well as minority groups (23).
In a study conducted in England, the views of parents concerning their
perceptions of the process of being diagnosed of an autistic spectrum disorder were
reviewed. At the time of diagnosis, most of the parents preferred quicker results
and an easier process. They also requested greater professional training regarding
ASD, specifically regarding information possessed by the professionals. The idea of
information sheets at the time of diagnosis would have been useful, especially in an
effort to prevent parents from finding information via unreliable sources (24).
Autism leads to developmental delays and nutrition can be an intervening
factor in slowing the poor outcomes of cognitive and physiological delay.
Prescription and non‐prescription medication use has been on the rise and plays an
important role including the aspect of nutrition. Many of the medications children
with autism are taking, have a positive correlation with nutritional intake.
Medications influence appetite, metabolism of nutrients, as well as their nutritional
status in general (13). Parents, who have not been educated on the role of
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medication use and its affect on nutrition, seek interventions and information from
less than credible sources. It is important for parents to realize that they can
influence their child’s nutritional status, allowing the child to realize the importance
of eating well and staying healthy.
The purpose of the study is to assess medicinal intake regarding prescription
and nonprescription medications of children with Autism Spectrum Disorders and
its affect on their nutritional status compared to age, and sex matched healthy
children. The information gathered will be used in educating parents who have
children with autism and practitioners in order to answer questions and/or clarify
misconceptions they may have with a newly diagnosed child.
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Chapter 2: Literature Review
Theories Surrounding Autism
The theories about the cause of autism are endless without any concrete
answers. Parents at times are feeling overwhelmed by new studies and suggestions
as they will do whatever it takes to make their child autism free. The impairments
of a child with autism affect their nutrient intake and eating behaviors. Some of
them generally eat only specific foods, have hypersensitivities to texture,
temperature, color and/or smell, and have a hard time transitioning due to the
inability to accept a change in environment. Many children with autism have
normal growth parameters; however, their dietary patterns place them at risk for
marginal to inadequate nutrient intake. Resistance to vitamin and mineral
supplementation is very common as well (25). Many experts combine
environmental and genetic factors as the cause. As the debate on the cause of
autism heats up, many have become passionate regarding the issue as they have a
family member or know of someone linked to autism.
Vaccinations
One theory commonly discussed for the cause of autism is vaccines. Vaccines
and autism have been linked twice with the first regarding the Mumps‐Measles‐
Rubella (MMR) vaccine. The vaccine may cause intestinal problems leading to
autism’s development. The MMR vaccine does not contain thimerosal, currently but
does contain three live viruses and is given around the same time that autism
becomes evident in a child that is diagnosed. The concern became apparent when a
British gastroenterologist, Dr. Andrew Wakefield, found a link between the measles
13

virus in the gut and autism. The theory entails that certain children have a
predisposition to immune issues causing environmental toxins to attack a child’s
immune system early on. Furthermore, the child develops a leaky gut, the immune
system is weaker, tissue damage is worse, and the autoimmune reaction starts.
When the immune system is overwhelmed, the child suffers from the effects of
autism (26).
A second theory is linking thimerosal, a mercury‐based preservative that was
used between the late 1980s to 2003. The type of thimerosal used is cleared from
the body within six weeks, rendering it harmless. There are researchers however,
that feel that some babies during that period were genetically incapable of clearing
the doses from their body. Many discussions on the Internet link the recent rise in
autism cases to thimerosal. The discussion continues and the removal of
thimerosal from vaccines has not lowered the autism vaccine connection. For some
parents who are concerned about the effect of thimerosal, vaccines are now
available, thimerosal‐free (27).
Brain Size
Researchers have found a difference between autistic brains and the typical
brain in which autistic individuals tend to have a larger brain. They have also found
that they are programmed differently. The University of Pittsburg has ongoing
research regarding the issue. A University of Louisville researcher, Manuel
Casanova, may have found a link between autism, ADHD, and dyslexia. A decade
ago, Casanova and his colleagues earned a National Institute of Health EUREKA
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prize valued at $888,000 in the form of a grant. His research identified differences
in brain tissue known as cortical cell minicolumns. These mincolumns connect
brain signals, which in turn process information. In people who have autism, there
was an abundance of short connectors, and deficiencies of long ones were found.
Those that are considered long are those that process complex information (28).
Analyzing MRI brain scans of fifteen dyslexic patients, Casanova discovered
that the dyslexic brains were exactly the opposite of the autistic brains. It was found
that the autistic brains were larger with the dyslexic brains smaller and with fewer
wrinkles. The dyslexic brains also had an abundance of long connections between
the cortical cell minicolumns, at the expense of short ones. Casanova is following up
with research through a clinical trial using high frequency magnetic waves. This
would in turn help those with dyslexia to make the short connections, allowing them
to read easier. Already utilizing a similar therapy using low magnetic waves on
autistic individuals, he has found success. If this is utilized and proven beneficial,
this could lead to treatment that does not involve the use of prescription medication
(28).
Genetics
Autism is also considered to have a genetic component. Studies have shown
that parents who have autistic family members are more likely to have autistic
children. Families with one autistic child are at an increased risk of having more
than one autistic child (26). Research has focused on genetic causes due to the rise
of families who have multiple children with the disorder. Approximately, 10
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percent of autism cases have a known genetic cause. Boston researchers think there
might be a gene glitch that accounts for 1 percent of the disorder. The finding was a
segment of chromosomes that were either missing or duplicated in people with
autism. This segment includes genes that are linked to brain development as well as
various developmental disorders. In some cases, the gene was inherited in others, a
result of random genetic accident (29).
Dr. Andrew Zimmerman, director of the Kennedy Krieger Institute’s Center
for Autism & Related Disorders in Baltimore, Maryland, predicted that children who
were newly diagnosed would be tested for the defect located on chromosome 16;
however, more DNA samples are needed to potentially reveal other gene variations
in relation to autism. When the biological pathways are determined, scientists will
have a better understanding when it comes to designing drugs to target chemicals in
the brain (29) that will not impede nutrition status while treating autism.
A study conducted at the Children’s Hospital Boston by Dr. David Miller,
scanned all 46 chromosomes from DNA samples from 1,441 children with autism or
related disorders. They also scanned DNA samples from most parents and 2,800
other people, not known to have autism. Researchers found a 25‐gene segment of
chromosome 16 was missing in five children with autism with none of their parents
demonstrating the missing link, demonstrating that some cases are not genetically
inherited, but a random accident during sperm and egg formation. Additionally,
seven autistic children had chromosome 16 duplication with all but one parent
having the same duplication (29).
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Serotonin
The imbalance of serotonin in the body is believed to cause many of the
characteristics noted in autism. Serotonin is responsible for regulating many
functions within the body such as mood, sleep, speech, body temperature, appetite,
and sensory integration. Low levels of serotonin can also affect migraines,
depression, PMS, insomnia, obsessive‐compulsive behavior and panic attacks. If
there is an imbalance, one can imagine the impact it must have on an individual.
When an imbalance occurs, the neurotransmitter, serotonin, does not properly carry
the message to the appropriate area of the brain. The serotonin instead is
prematurely taken away for reuse in the re‐uptake process thus not allowing the
brain to receive and make sense of an incoming message. Serotonin is synthesized
in the chromaffin cells of the gut, specifically 80 percent (30).
The chemicals and neurotransmitters have a vital role in the function of the
brain and the rest of the body as examples such as dopamine, serotonin and
norepinephrine are dependent on proper digestion. When these neurotransmitters
are not functioning properly, the likelihood of a malfunctioning digestion system
increases. Children with autism tend to pose issues regarding digestion and stool
abnormalities and have chronic indigestion and gas. In a group of randomly
selected autistic children, 40 percent were found to have bulky, odorous, loose
stools or diarrhea. Many parents also report that their child appeared to have
worsening behavioral symptoms due to gastrointestinal problems (30).
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Gastrointestinal Tract
Gastrointestinal examinations on children with autism found that signs of
chronic inflammation in the gut, esophagus, stomach, and duodenum are seen. Due
to enzymatic deficiencies, many children have trouble digesting and absorbing
carbohydrates, which could potentially be linked to the loose stools and gas. When
children with autism have digestive difficulties, it is noted that behavior changes
occur such as aggression, irritability, as well as the potential for waking up during
the night (30).
Scientists have begun to make a connection to the gut and brain in relation to
autistic‐type behavior within a laboratory setting through compounds produced in
the digestive system. This could prove that the brain function in an autistic child
could be altered through what they eat. The University of Western Ottawa
investigated the “gut‐brain” connection due to families reporting increased
improvements in behavior once their diet was modified, removing wheat and dairy
products. Dr. Derrick MacFabe, director of a research group at UWO in London,
Ontario, was interested in finding a link between certain compounds produced by
bacteria within the digestive system. These compounds usually occur during early
childhood infections. The bacteria produce propionic acid, a short chain fatty acid.
The bacteria are found in dairy and bread products (31).
In order to test their theory, researchers gave the compound to rat’s brains.
The rats immediately began to demonstrate repetitive behavior as well as
hyperactivity and impaired social behavior. These behaviors are typically seen in
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children with autism. The rat’s brains were reviewed under a microscope and
inflammatory responses were seen just as those in the brains of children with
autism. Dr. Martha Herbert, assistant professor in neurology at Harvard Medical
School, states that parents should monitor what they feed their child in an effort to
determine which foods trigger their reactions and proceed to remove them if
necessary. Herbert recommends a balanced diet, not only of bread and cheese, but
also of all food groups. The recommendation is that if the child is sensitive to
certain foods in relation to their immune system, which can affect brain function,
that the food should be removed (31).
There is also the hypothesis regarding a child with autism having a “leaky
gut.” The theory centers on the integrity of the intestinal mucosal lining also
referred to as the intestinal mucosal barrier. In children with autism, there is the
theory that the intestinal mucosa is abnormally penetrable. During the digestion
process, natural foods, such as cow’s milk and bread, are able to enter the blood
through the leaky mucosa, inducing antigenic responses as well as interfering with
the central nervous system. A defect in the passage of neuroactive peptides of food
origin are found within the blood then travel into the cerebrospinal fluid, interfering
with the central nervous system (32).
A relationship is hypothesized between the behavior of children and adults
with autism and food reactivity and sensitivity. Gluten and casein contain peptides,
which are suggested in playing a role in the origin of autism. These substances may
have a physiological and psychological effect due to the excessive opioid activity
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linked to these peptides. Research through Millward et al. has found that those with
autism had abnormal levels of peptides in the urine as well as cerebrospinal fluid.
When high levels of peptides deposit into the urine, a small portion of the excess
peptides cross into the brain. This crossing leads to interference of signal
transmission as well as a disruption in normal activity (33).
One study by Knivsberg et al., 2002 argued that peptides from gluten and
casein have a negative pharmacological effect on behaviors such as social
interaction, learning, and attention. If children and adults with autism were placed
on a diet that was appropriate, it would aid them in cognitive functioning, brain
maturation, social interaction, and learning. If the theory is true regarding a gluten
free and/or casein free diet, then the symptoms associated with autism should be
reduced (34).
Elder et al. in 2006 conducted a study looking at the gluten‐free, casein‐free
diet in autism. Fifteen children diagnosed with ASD ranged in age from 2‐16 years.
Purposive sampling from the Center for Autism and Related Disabilities and/or
Child Psychiatry Services at the University of Florida’s Department of Psychiatry
and Brain Institute chose them. The sample consisted of three girls and twelve boys.
A research assistant trained in videotaping techniques, video‐taped each child
interacting with their primary care‐taking parent during 15 minute sessions.
Trained coders used the video footage to obtain behavioral counts of the parent and
child. Status of subjects was unknown to coders with regard to the treatment phase.
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Symptoms that were measured included social responding, non‐speech
vocalizations, social initiating, and intelligible words spoken (35).
Results showed that parents of seven children reported that there were
marked improvements in the child’s language along with decreased hyperactivity
and tantrums. Parents of nine of the children decided to keep the child on the GFCG
diet even when there was not empirical support for its continuance. A larger scale
study would be beneficial for further research (35).
The nutrition connection to autism is further theorized in discussions that
excess dietary iron is responsible for the increased rates of autism and allergies.
Enzyme therapy, vitamin therapy, and the ketogentic diet are also included in the
debate and as subjects of studies. In some cases of autism, food allergies or
sensitivities, which lead to behavioral issues, appear to be involved with autism
(36).
Complementary and Alternative Medicine
“Biological treatments” or “biomedical treatments” are also part of the
discussion that supports a nutrition metabolic interaction. These treatments are
proposed to alter physiology or change the symptoms of autism by manipulating
metabolic processes. Typically, they are administered via parenteral, oral, or topical
modes and exclude treatment involving prescription medications used to treat
traditional behavior or medical disorders. Many complementary and alternative
medicines are not “biological,” however; they have the ability to alter physiological
processes such as touch, manipulation, movement, or other senses. Some medical
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practitioners have formulated a group called Defeat Autism Now! otherwise known
as DAN. There are suggestions from the DAN! practitioners to use nutritional
supplementation which include, special diets, avoidance of allergenic foods,
treatment of bacterial/yeast overgrowth, and detoxification of heavy metals (21).
Complementary and alternative medicine are defined by the National Center
for Complementary and Alternative Medicine, as “a group of diverse medical and
health care systems, practices, and products that are not presently considered to be
part of conventional medicine” (5). Immune factors have been studied regarding
some cases of autism specifically using complementary and alternative medicine as
a hypothesis. The assumption is that the symptoms of autism are linked to brain
damage secondary to immunologic response to infection or autoimmunity and
immune deficiency. Although evidence for an immune deficit in children with
autism is inconsistent, several CAM therapies connect immune mechanisms in an
effort to justify their use (21).
The use of CAM in children has become more prevalent. A study of families
in the Washington, D.C. area found that 40 percent of parents reported using CAM
themselves and 21 percent used CAM with their children. CAM has also been
utilized in children with chronic illnesses including cancer and cystic fibrosis (37).
The use of CAM, specifically, in children with autism spectrum disorders, is very
common. One study found that by the time the clinical population received a formal
diagnosis suspecting ASD, one third of the population had already been given some
form of complementary and alternative therapy. A survey later found that 92
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percent of parents who responded had used CAM therapies on their child with ASD.
Surveys also indicated that only 36 to 62 percent of caregivers who used CAM
informed the primary care physician (5).
Healthcare providers need to realize the importance of the use of CAM and
recognize how to evaluate the evidence of its effectiveness. This should include
peer‐reviewed studies with diagnosed, study populations, random double‐blind
study, adequate sample size, the use of a control, and validated outcome measures
(5). They also need to familiarize themselves with current therapies available to
parents of children with autism through various sources such as the Internet,
alterative health practitioners, and medical and informational meetings. Another
issue needing to be addressed is the doctor‐patient relationship as it relates to
parental beliefs regarding the cause of autism. Parents of children with autism have
little confidence that most doctors know enough to treat children with autism.
Some physicians are unwilling to participate in treatment regimens that are not
evidence based. Parental concerns about treatment or complaints worsen and
cause them to begin seeking advice from individuals with little to no knowledge
(38).

23

An example of CAM therapy is categorized as “biological.” These examples
include dietary restriction of food allergens, detoxification therapies such as
chelation, gastrointestinal treatments, and dietary supplement regimens that
supposedly work on immune factors. These supplements include vitamin A and C,
vitamin B 6 and magnesium, folic acid, folinic acid, vitamin B 12 , dimethylglycine and
trimethylglycine, carnosine, omega‐3 fatty acids, inositol, various minerals, and
others (5).
Chelation
Chelation is a controversial treatment for children with autism and other
disorders. The treatment was originally for children with lead poisoning where a
child is dosed with several chemicals that bind and excrete mercury and other toxic
heavy metals. However, chelation therapy can also bind and remove essential
nutrients such as iron, chromium, selenium, and calcium from the body. The
therapy has caused controversy even though some experts have recommended
chelation. There are studies showing increased exposure to mercury and other
heavy metals however, few studies have been conducted demonstrating
improvements using this therapy and reports of at least two deaths have resulted.
Recommendations to minimize the stress of chelation, if used, include the use
of multivitamin and mineral supplements in an effort to replace lost nutrients. One
example is the use of cilantro extract, which has been suggested as causing a
naturally binding effect to toxic heavy metals such as mercury and lead. The
evidence is not strong for this CAM product, although practitioners are beginning to
recommend the herbal extract to patients undergoing chelation therapy (39).
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Vitamin B 12
Vitamin B 12 deficiency has been known to impair nervous system
development; this is according to the theory that impaired intestinal absorption of
the vitamin results in impaired nerve function, specifically. The dietary form of
vitamin B 12 is absorbed in the ileum of the small intestine. The ileal mucosa in
autistic patients has the potential to interfere with transport process in the ileal
absorptive cells. When absorption is inhibited, the vitamin B 12 in the blood is low,
interfering with the formation of myelin. Myelin is needed for normal conduction of
action in nerve fibers. Researchers observed that vitamin B 12 absorption was
reduced in all eight autistic individuals participating in a study (32).
Vitamin B 6 and Magnesium
Studies indicate that vitamin B 6 as well as magnesium supplements have a
positive impact on autism spectrum disorders. Magnesium levels in the blood were
found to be lower in children with autism and it has been reported that magnesium
supplementation has been beneficial to those with ADHD. Some children with
autism may suffer from anxiety or depression. Vitamin B 6 has the ability to increase
GABA and serotonin in the blood as well as reduce dysphoric or unhappy mental
status (40).
Minor side effects of CAM and medications include nausea, diarrhea, or
hyperactivity. Nausea can result if the medication is taken on an empty stomach;
therefore compounding nutritional concerns. Research reports indicate that a small
number of children who took very large doses of B 6 suffered from peripheral
neuropathy, causing numbness of the hands and feet. Dr. Bernard Rimland of the
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Autism Research Institute recommends that children receive approximately 8mg of
vitamin B 6 per pound of body weight each day or 500mg for a 60‐pound child (41).
Research indicates that 50 percent or more of those treated with
supplements made significant improvements. Some of whom have been only on the
supplements within a matter of days. A major study conducted in 1968 revealed
that of 16 children with autism, 75 percent of them made dramatic improvements
due to the intake of vitamin B 6 . Three of the participants spoke for the first time.
Other changes included better eye contact, greater interest interacting, and fewer
outbursts consisting of temper or emotion. Although participants were not cured,
their ability to function increased. The study overall demonstrated that through the
use of vitamin B 6 along with normal doses of magnesium that a person with autism
could have better control, behaviorally, than with prescribed medication. A survey
from the Autism Research Institute found that parents felt the supplementation was
beneficial with 50 percent seeing improvements utilizing the B 6 and magnesium
combination, while 45 percent saw no effect and 5 percent stated their child became
worse (42).
Omega3 Fatty Acids
Another supplement suited for possible beneficial effects revolved around
omega‐3 essential fatty acids. Omega‐3 fatty acids are among the most commonly
used complementary and alternative medication therapies, currently used by 28.7
percent of children with autism (43). However, many modern diets tend to be
deficient in omega‐3 fatty acids and in the 1970s, it was discovered that omega‐3
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fatty acids were essential to human health. Omega‐3 has the ability to affect the
structure of brain cells and affect the way the brain cells work; therefore,
supplementation has been proven beneficial in patients with depression,
schizophrenia, and postpartum depression (44).
Two cases have been published with families noting large improvements in
the core feature of autism when supplemented (43). There have been minimal
studies demonstrating the success of omega‐3 supplementation; however, research
has shown that children with autism tend to have lower levels of the omega‐3 fatty
acids versus typical children, suggesting that normalizing the omega‐3 fatty acid
levels could lead to improvements in symptoms seen in children with autism (44).
Folic Acid and Vitamin B 9
Folic acid has made it into the literature as a possible nutrient involved in
autism. An increased use of folic acid is recommended during pregnancy in the
prevention of neural tube defects, however, researchers question if there are
downsides to the increased amount. Normal fetal development apart from closure
of the neural tube, depends on folate intake, however, scientists are wondering if the
increased intake of folic acid has a link to autism (45).
Vitamin B 9 or folate is critical to brain function and synthetically can be
found in fortified food and supplements. Folinic acid, a derivative product, can be
processed more rapidly into a specific type of foliates which can be directly
transported to the brain. Folinic acid can be used to increase glutathione, an
antioxidant, in the brain of children with autism. It also has the ability to increase
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the level of dopamine that may prove to be beneficial in children with autism.
Critical in cell production and maintenance, folinic acid can help prevent DNA
changes that can lead to cancer. Folate is also useful in treating conditions such as
depression. Persons with depression are more likely to have low levels of folate and
taking a supplement may reduce depressive symptoms in some cases. Along with
taking vitamin B 9 , the addition of B 6 and B 12 can play a role in the treatment of
depression (46).
Of all B vitamins, people are the most deficient in B 9 . When deficient, an
individual may notice slow physical growth, tongue inflammation, loss of appetite,
gingivitis, forgetfulness, diarrhea, shortness of breath, mental sluggishness, and
irritability. Long‐term use of antibiotics has the ability to deplete levels of vitamin
B 9 in the body. It is found naturally in dark leafy greens such as spinach as well as
beets, lima beans, white beans, soybeans, Brussels sprouts, avocados, milk, and
orange juice. Folate is more effective when taken with vitamin C. One researcher
found that 250 mcg per pound of body weight daily resulted in improvement for
some children with autism. At the Autism Research Institute, 48 percent noted
improvements compared to 44 percent who saw no effect and 8 percent who stated
their child became worse (41).
Vitamin C
Vitamin C has many vital functions, including a cofactor in the conversion of
tyrosine to dopamine, an antioxidant, and it regulates cellular immune function.
The use of supplementation of vitamin C increases a calming effect, through the
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brain’s response to the neurotransmitter dopamine. The reduced behavior was
noted with people and when tested on animals. This same behavior can be noted
among those with autism spectrum disorders. Children with autism are also
deficient in vitamin C as they have lower levels in their body than the typical child
does. Another theory is antioxidant benefits. It has been thought that children with
autism have a difficult time managing free radicals in their body. Free radicals have
the ability to cause damage to the immune system as well as the brain and other
parts of the body. Vitamin C has the ability to protect against the effects of free
radicals decreasing potential damage (47).
Another effect of vitamin C is its use among those who suffer from
schizophrenia or depression. It has been shown to have a beneficial effect on the
patient’s symptoms. Persons with autism have been linked to having depression as
well as an inability to function socially and high doses of vitamin C have been shown
to aid in those symptoms. A study conducted in 1991, using adults and adolescents
with autism found that a dose of 8,000 mcg of vitamin C a day demonstrated
increased improvement. In 1993, another study was conducted in order to find out
whether vitamin C would be beneficial for those with autism. The results showed
that although vitamin C was not as effective as the use of vitamin B 6 , a high dose
could potentially prove to be beneficial. A 2004 study was conducted in which the
gastrointestinal problems seen in children with autism were improved as well as
their sleeping patterns, when using vitamin C (41).
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Researchers from the Autism Research Institute found that 46 percent of
parents thought that vitamin C demonstrated improvement in their child while 51
percent saw no change and 2 percent saying their child grew worse. Since vitamin C
is a water‐soluble vitamin, it can be taken in rather large doses without any serious
side effects. However, in high doses, it can act as a laxative, leading to dehydration.
The tolerance of vitamin C is different from person to person and other medical
conditions should be taken into account before starting a patient on
supplementation (47).
Dimethylglycine (DMG)
Dimethylglycine (DMG) is a dietary supplement that also has been reported
to be beneficial in children with autism (48). Studies have typically been informal,
however, adding the supplement has suggested improving speech and other factors
when taken with vitamin B 6 and magnesium. DMG has also demonstrated the
ability to suppress seizures in people with epilepsy. There are clinical trials that
suggest the enhancement of muscle energy and decreased factors that contribute to
muscle cramping. There are studies that link DMG to the immune system as it has
the potential to ward off Salmonella. Other claims to DMG include improvement in
eye contact, frustration tolerance, speech, social behavior, and aggression (49).
On the other hand a study conducted by Kern et al., examined the
effectiveness of DMG. The study used thirty‐seven children between the ages of 3
and 11 who had a diagnosis of autism and/or pervasive developmental disorder.
The participants were gender and age matched and assigned randomly to receive
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placebo or dimethylglycine for 4 weeks. Assessments were conducted using two
behavioral measures, the Vineland Maladaptive Behavior Domain and the Aberrant
Behavior Checklist. Overall improvement was measured regarding all aspects of
behavior for groups, placebo and supplement. The findings demonstrated that the
use of the supplement was not significantly different in children observed who
received the placebo (48).
Medications and Autism
Medications can have multiple effects on the body’s absorption, retention,
metabolism, as well as nutrient status. Adverse reactions can be provoked in
combination with certain foods having the ability to influence appetite, by either
repressing it or artificially stimulating it. Certain medications have the ability to
increase the absorption of nutrients, or more commonly, decrease absorption,
which can sometimes lead to clinical deficiencies. Medications can also induce
mineral and vitamin deficiencies by their mode of action and transport (50).
Drugs affect our use of food just as food affects the use of drugs. Food is
capable of affecting drug absorption in a number of ways. Food can impact
subsequent distribution and metabolism of drugs. Vitamins can interfere with drug
effectiveness, especially if taken in large doses. However, large doses of certain
vitamins have the ability to counter certain toxicity conditions or a specific
secondary deficiency induced by a genetic disease (50).

31

The treatment of autism includes not only behavioral therapy modifications,
but pharmacologic therapy. There has been a lack of data in the use of medications
in those with pervasive developmental disorders. Within the last 10 years, clinical
research has increased in an attempt to provide data regarding efficacy and safety
as a way to support the use of these medications. There is increased evidence that
atypical antipsychotics have the ability to treat symptoms associated with PDDs
including aggression, self‐injury, and irritability while data for others are limited
(51).
Antidepressant medications, selective serotonin‐reuptake inhibitors, are
primarily used to treat anxiety, depression, or other obsessive‐compulsive
symptoms in patients with PDD. They are typically prescribed for those who exhibit
severe behavioral problems including irritability and aggression. Medications for
those with seizures or mood disorders are prescribed anticonvulsants. Those with
attention deficit disorders are given stimulant medications. Other medications
include beta‐adrenergic blocking agents, alpha‐adrenergic agonists, mood
stabilizers, anticholinesterase inhibitors, anxiolytics, and naltrexone (52). In autism,
all of these symptoms may be present.
Atypical Antipsychotics
Atypical antipsychotics have gained popularity as a new treatment option for
those with PDD, which include Risperidal, Zyprexa, Seroquel, Geodon, Abilify, and
Clozaril. Risks do appear such as weight gain and an increased risk for metabolic
syndrome (51). Metabolic syndrome is a combination of risk factors that include
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insulin resistance, hypertension, abnormal blood lipids, and abdominal obesity that
has the ability to increase an individual’s risk for developing heart disease (53).
Antipsychotic drugs work by influencing how information is transmitted
between brain cells. An adult brain has over 10 billion nerve cells called neurons
with each neuron containing a fiber called an axon. Axons are responsible for
transmitting information to other neurons and they make contact with other
neurons in the body. As information travels down the axon, an electrical impulse
occurs. When this impulse reaches the end of the axon, a small amount of
neurotransmitter is released allowing information to be passed to the next cell
down the line. There is a receptor at the receiving cell that detects the
neurotransmitter causing the message to be received generating a new impulse.
Sometimes there is excessive activity of the cells sensitive to the neurotransmitter,
specifically dopamine; therefore, antipsychotic drugs block receptors so that
communication between groups of cells is reduced (54).
Risperidal (risperidone)
Risperidone was the first atypical antipsychotic to be rigorously studied
demonstrating consistent efficacy (51). It is thought to work by muting the impact
of dopamine and serotonin, the brain’s key chemical messengers. Side effects
related to nutrition include, abdominal pain, constipation, diarrhea, decreased
activity, increased sleep, indigestion, nausea, over activity, sleepiness, vomiting and
weight gain. Evening primrose causes an interaction with risperidone as well (55).
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One study, conducted by Research Units on Pediatric Psychopharmacology
Autism Network, lasted eight weeks and evaluated the safety and efficacy of
risperidone in children with autism. A total of 101 patients were enrolled with 49
being assigned to risperidone and 52 assigned a placebo. After the eight‐week
treatment period, those treated with risperidone had significantly decreased their
irritability score compared with those who took the placebo. However, the most
common side effect was increased appetite, lethargy, and sedation, all of which
having the potential to effect nutrition. Those on risperidone experienced an
average weight gain of 5.1 +/‐ 3.6 kg over 6 months or 11.22 +/‐ 7.92 pounds. This
was a significant gain versus those receiving the placebo. A separate study found
that risperidone had a 2.7 kg versus 1kg weight gain where increased appetite,
tachycardia, and increased systolic pressure were reported. Weight gain was also
evident in a study conducted by Luby et al. in which a 2.96 kg +/‐ 2.53 kg weight
gain was observed (56).
Zyprexa (olanzapine)
Zyprexa is another type of antipsychotic used for children with autism.
Zyprexa works by opposing the action of serotonin and dopamine. Their nutritional
side effects include abdominal pain, constipation, dehydration, drowsiness, dry
mouth, fever, increased appetite, indigestion, insomnia, nausea, restlessness, weight
gain, dental pain, diabetes, sleepiness, sore throat, swelling of arms and legs, thirst,
and vomiting. Sometimes Zyprexa can cause drowsiness, impairing judgment,
thinking and motor skills and drinking plenty of fluids is recommended while taking
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this medication. Avoidance of alcohol should be noted as, in combination, a drop in
blood pressure could occur (55).
In a study utilizing Zyprexa, the most prominent adverse events were
increased appetite and weight gain in 6 subjects and sedation in 3 subjects. The
mean weight gain increased from 137.5 pounds at baseline to 155.9 pounds after 12
weeks of treatment. In another study comparing Zyprexa to haloperidol, weight
gain was significantly higher in Zyprexa ranging from 5.9 to 15.8 pounds versus ‐5.5
to 8.8 pounds in those taking haloperidol. Another study involving 11 subjects
demonstrated a weight gain of 7.5 pounds (56). Kemner also noticed a weight gain
during their 12‐week open‐label trial of 25 children with autism. There were a
reported 14 cases each of weight gain, general weakness, and increased appetite.
The average weight gain was 5.8 kg or 12.76 pounds (51).
Geodon (ziprasidone)
A third type of atypical antipsychotic used is Geodon, working the same way
as it opposes the action of serotonin and dopamine. Geodon is typically prescribed
when other medications have proven to be inadequate. Nutritional side effects
include, abdominal pain, constipation, diarrhea, drowsiness, dry mouth, indigestion,
nausea, bleeding gums, coordination problems, difficulty swallowing, high blood
sugar, increased sensitivity to sound or touch, involuntary or jerky movements, low
blood sugar, muscle pain and weakness, thirst, vomiting and weight gain. The
medication may cause drowsiness, which can impair judgment, thinking, and motor
skills (55).
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A study using 12 subjects was reviewed. Transient sedation was the most
common adverse event with a mean change in weight being ‐5.8 pounds. The
weight loss was linked to a number of subjects who were switched from other drugs
that had caused substantial weight gain. The weight gain noticed in previous
therapy was 9.1 to 45.5 kg (56). Cohen et al. conducted a 6‐month study and found
that eight patients lost weight at ‐5.95 +/‐ 0.45 kg, however, one patient gained 4.5
kg and another had stable weight post treatment (52).
Seroquel (quetiapine)
Seroquel is another medication used to combat delusion, hallucinations,
disrupted thinking, and loss of contact with reality. It is the first in a new class of
antipsychotics. It works by diminishing the action of dopamine and serotonin.
Nutritional side effects include abdominal pain, constipation, diminished movement,
drowsiness, dry mouth, indigestion, tremor, uncontrollable movements, weakness,
difficulty breathing, loss of appetite and weight gain. This medication also tends to
cause drowsiness, impairing judgment, thinking, and motor skills. It can also
increase the effects of alcohol (55).
There are not many published studies regarding Seroquel, however, Martin
and colleagues conducted a 16‐week study in six children and adolescents with
autism. Three subjects withdrew due to sedation and one dropped out due to a
possible seizure. Increased appetite and weight gain, 2 to 18 pounds, was reported.
It was concluded that Seroquel was poorly tolerated in this group. In another study,
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significant improvement was noted with adverse reaction being mild, which
included sedation, sialorrhea, and weight gain (56).
Possible Weight Gain
It is not surprising that weight gain is seen in these studies regarding the
medications prescribed. Children on psychiatric drugs can easily gain a substantial
amount (57). The most concerning aspect of these drugs is that they are not yet
approved for children. The drugs also include a long list of side effects ranging from
abnormal limb and body movements, seizures, and rapid heart beat. At times, the
drugs are prescribed “off label.” Antipsychotics were also the highest earning class
of drugs last year bringing in approximately 14.6 billion dollars (58) and raising
doubts about its misuse to fuel the profit margin especially with autism being the
fastest growing disorder.
In one study, children gained up to 20 pounds leading them into obesity
within 11 weeks. The percent range of those who became obese was between 10
and 36 percent. The study involved 205 New York City area children ranging in age
from 4 to 19 who had been recently prescribed one of the antipsychotic drugs.
Those drugs prescribed included Abilify, Risperdal, Seroquel, and Zyprexa. Of the
four, Zyprexa and Seroquel, not yet approved for children, had the worst side effects
regarding weight and cholesterol. However, a government advisory panel voted in
favor of dosing it for children with the drug companies making “off label”
recommendations (57).
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Dr. Christopher Varley has noticed growth in patients between visits.
Although weight gain is seen as a possible side effect for antipsychotic drugs, a new
study is finding that the older children and teens are more prone to the weight gain
than adults. Increases in blood fats including cholesterol were also viewed in not
only adults but children as well. Weight gain is seen as a contributing factor and
there is increased worry that the children will be more prone to heart disease as
they get older (57).
Drug makers state that the drugs do pose problematic side effects but
emphasize the overall benefit of the patient coping with various behaviors. The new
class of drugs is overall safer than its predecessors, which at times caused
permanent involuntary muscle twitches and tics. The number of children using
these drugs has increased substantially to more than 2 million annually (57).
Johns Hopkins brain scientists, however, think they have found the reason
for weight gain, as they believe they have found the connection between
antipsychotics and brain chemicals that trigger appetite. Previous research had
found a particular enzyme, AMPK, was increased in brain cells, acting as the control
lever for appetite in mice and essentially humans. There was a suspicion that AMPK
would spike when antipsychotic medications were taken, causing the brain to
overact. In order to prove this, the Johns Hopkins team injected mice with Clozaril,
Zyprexa, and Risperdal. The mice that were given Clozaril had quadrupled their
levels of AMPK compared to pre‐drug use. Histamine, a cell‐signaling protein, is also
being studied as it relays information from cell to cell. Typically, it is used to trigger
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allergy symptoms, however, it activates AMPK the same way Clozaril does. When
given Clozaril to mice, without a histamine receptor, they found no heightened
AMPK activity. This could be a potential breakthrough in researching weight
control and possibly aid in creating drugs that suppress appetite safely (59).
Dietitians have the ability to play an important role in weight control in those
taking antipsychotics. A research team from Universite Lava’s Faculty of Medicine
and Robert‐Giffard Hospital demonstrated weight gains as much as 30 kilos in one
month. Therefore, their idea was to design a special weight control program. A
psychiatrist and kinesiologist supervised the researchers. The effectiveness of the
program was used on a group of 59 patients suffering from schizophrenia and
psycho‐affective or bipolar disorders having used antipsychotic medications for an
average of three years (60).
A 90‐minute session regarding healthy eating and physical activity was
implemented. The participants then took part in two one‐hour workout sessions
once a week for an 18‐month period. Exercises included aerobic and muscle
building supervised by the kinesiologists. At the end of the study, those who were in
the weight control program saw their average weight, waist size and body mass
index decrease by 4 percent or more. The levels of HDL cholesterol went up 21
percent while LDL cholesterol decreased by 14 percent. Triglycerides also
decreased by 26 percent (60).
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Nutrition plays a vital role in the medication use of children with autism.
Already suffering from a long list of behavior and feeding issues, medications should
allow individuals to have a level playing field. The decision for parents on what
medications to dose is a difficult one as research is of top priority. Therefore, much
research needs to be conducted to obtain answers, scientifically, rather than
through other measures.
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Chapter 3: Research Objectives
The objectives of the study are fourfold:
1. To assess the nutritional intake of children with autism in comparison to the
typical child
2. To examine the sources parents use to collect information regarding drugs,
prescription and nonprescription
3. To determine the extent to which parents use complementary and
alternative medicine as intervention
4. To examine the amount of weight gain due to the use of prescription
medications
Hypotheses
H1: Parents will use complementary and alternative medicine more than
prescription drugs in the treatment of a child with autism
H2: Over half of the parents will note a weight gain of four pounds or more in
their child in relation to prescription drug use
H3: More than half of the parents will utilize the Internet as their only source
of information when researching various drugs both prescription and
nonprescription
H4: Children with autism will demonstrate deficiency in vitamin B 6 ,
magnesium, calcium, and vitamin B 12 compared to the typical child
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Chapter 4: Methodology
The study has been approved through the Institutional Review Board at the
University of Kentucky and all study administrators have completed the research
integrity training. Consenting families received an initial consultation in the
research office located in 212 Funkhouser Building. Study consent forms were
explained and parents were given time to ask questions before being enrolled in the
study. Anthropometric measurements were taken of the child including a height,
weight, head circumference, waist to hip ratio, and triceps skin fold measurement. A
comprehensive nutritional health history along with a prescription and
nonprescription history for the child were obtained. These histories recorded
maternal and perinatal patterns, oral health, history of chewing and swallowing
problems, medication and supplement use, and gastrointestinal symptoms.
A 24‐hour recall of the child examined was recorded. A 24‐hour recall is a
method of dietary assessment in which an individual is asked to remember
everything eaten within the last 24 hours. The items are to be very specific
regarding amounts and types of foods. The individual gathering the data analyzes
the information. Several problems occur when using this method of data collection.
The first is an inability to remember, specifically, the kinds and amounts of foods
eaten. The second is difficulty in determining whether the day represents a typical
day in their life. The third is the tendency to over report low intakes and under
report high intakes of food. The use of food frequency and 24‐hour recall
questionnaires aid in improving accuracy (25).
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The multiple pass method was used to administer the 24‐hour recall. This
method allows the interviewer to trigger memories in the individual that recall what
foods they have eaten in a specific period. In a 5‐Step Multiple Pass Method, the first
step includes having the individual list all the foods they have eaten in no particular
order, specifying a 24‐hour time frame, midnight to midnight for instance. One food
per line typically is written. The next step is to allow individuals to recall or
remember foods forgotten that may have been eaten within the 24‐hour period
giving participants time to respond. The third step includes asking about special
occasions or functions that they might have attended. This could include a specific
meal or snack and activities with the family. It is oftentimes beneficial to give some
examples of activities. Next, go back through the foods obtaining details such as the
brand name of the food, how it was prepared, with or without bones or skin, frozen,
raw or canned, and how much was eaten. The last step is to the have the participant
look over the recall to see if anything else needs to be added (61).
An abbreviated questionnaire regarding medications currently taken by the
child was completed. A more thorough questionnaire concerning medications and
the use of complementary and alternative medicines (CAM) was administered to a
wide pool of families via listservs, which include families who have children with
autism including The KYautism, Autism Society of the Bluegrass, and FEAT. The
questionnaire focused primarily on parental perceptions of the success or failure of
the medication, side effects such as weight gain or weight loss, decreased appetite,
and recommendation of nonprescription drugs and its effects within the last two
years.
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The electronic program, SurveyMonkey, created structure for the
questionnaires. The survey was divided into several constructs when analyzing the
results. The first construct regarded the use of prescription and nonprescription
drug within the last two years. Two years was utilized in order to give the most
recent drug utilization. This is due to children with autism being prescribed a
variety of drugs as well as parents trying various over the counter products. The
second construct enabled parents to choose from a listing of the top prescription
and nonprescription options mostly used in children with autism. If a drug was not
listed as an option, the parent had the opportunity to list what their child was
taking. The third construct focused on any type of side effects that they noticed in
taking either prescription or nonprescription drugs.
The next construct questioned the effectiveness of the prescription and
nonprescription drug as well as if the prescription drug caused any weight gain.
The responses were listed on a Likert‐like scale. The last construct was in reference
to the initial recommendation of the nonprescription drug as well as the likelihood
that the parent reported its use with a healthcare professional, primarily the child’s
physician.
The questionnaire was pre‐tested with a total of 10 families and graduate
students, within the Nutrition and Food Science Department, in an effort to
determine the validity of the questions. Data gathered within the SurveyMonkey
questionnaire in regards to prescription use was ranked according to the top
prescriptions utilized today as reported by various research articles where limited
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studies have been conducted regarding their use. The top complementary and
alternative medicines were analyzed for parents’ report of their effectiveness on the
child along with the impact of the medication on nutritional intake. This data
allowed for the collection of the parent’s perceptions of the various medications
used within the two‐year period.
The 24‐hour recall regarding nutritional information was collected from
children with autism and compared to the intake of typical children reported under
the United States Department of Agriculture between 2005‐2006. The data was
utilized as a comparison between children with autism and typical children,
specifically looking at essential vitamins and minerals. These levels were compared
to the recommended dietary allowance (RDA) or adequate intake (AI) in an effort to
see where each child lies in nutritional status. This will also allow us to recognize if
there is a significant difference between the nutritional intake and nutritional
deficiency, specifically in regards to a child with autism.
Statistical Analysis
Data was analyzed using the statistical package for the social sciences,
otherwise known as SPSS 16.0. Statistical tests were applied, specifically regarding
the nutritional intake of typical children versus the child with autism. The nutrients
that were analyzed include those in direct relation to autism spectrum disorders as
previously mentioned, such as vitamin B 6 , magnesium, calcium, etc. Significance
was assumed at the .001 level.
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Subjects
In regard to the online survey through SurveyMonkey, 26 parents completed
the questionnaire. The children represented all ages of autism spectrum disorders
and their parents or caregivers were sent questionnaires via listserv. Some of the
subjects were recruited to participate at an annual fall festival for children with
autism as well. All children in the study population had a diagnosis of autism,
Asperger syndrome or pervasive developmental disorder – not otherwise specified
from a certified physician or clinician. The results were tested for frequency in
regards to the five constructs reported earlier. Relationships were analyzed and the
results are to follow.
The total number of responses regarding 24‐hour recalls was 15; however,
the quantity of children used was 13. The age category had to be taken out as p‐
values were giving the same results across the board. Typical children were
matched from the USDA nutritional intake survey by age and gender to the children
with autism (62). In analyzing the data, each vitamin and mineral was categorized
by the recommended daily allowances as below normal, normal, or above normal
levels. The nutritional status was then reviewed in the child with autism and the
typical child, found within the USDA study. Proper RDAs for males and their age
ranges were maintained and taken into consideration. The data was then analyzed
using SPSS version 16.0.

46

Inclusion Criteria – Experimental Study Population
• Male or female children between the ages of 1‐14 years old with a clinically
documented diagnosis of autism, Asperger syndrome, or pervasive
developmental disorder – not otherwise specified, and their parents or
legal guardians
• Children were healthy and had no other medical diagnosis that would
impact nutrition status
• Children and their parents or legal guardians must be a resident of the
State of Kentucky
• Children were not institutionalized but lived in the family home
Inclusion Criteria – Control Study Population
• Male or female children between the ages of 1‐14 years old with no
suspected or clinically documented diagnosis of autism, Asperger syndrome,
or pervasive developmental disorder – not otherwise specified and their
parents or legal guardians
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Chapter 5: Results
The first section of review pertains to the constructs. Data was collected
from parents who have children with autism. The survey was made available
through SurveyMonkey and sent out to three various autism society listservs. A fall
festival for children with autism was also held in an effort to obtain data from those
parents in attendance. The questionnaire regarded the use of prescription and
nonprescription drugs pertaining to specific drugs used, their side effects, the
quantity used, and the source of information for utilizing the drugs. Responses were
analyzed and evaluated based upon frequency.
Construct 1: Prescription and Nonprescription Drugs and Number Used
Table 5.1: The Quantity of Prescription Medications Prescribed to a Child with
Autism
Within the past 2 years, how many medications have been prescribed to your
child, specifically for Autism?
Response
Percent

Response
Count

0‐2

73.1%

19

3‐5

23.1%

6

6‐8

0.0%

0

9 or more

3.8%

1

Answer Options

48

Answered question

26

Skipped question

0

Of the 26 people who responded, all 26 were utilized. Table 1a indicates that
the percentage of those using 0‐2 medications was 73% (n=19). Of the 26
participants, 23% used 3‐5 medications (n=6). Within the category of 6‐8, the
responses were 0% (n=0). Those who used 9 or more medications yielded 3.8%
(n=1).
Figure 5.1: The Quantity of Prescription Medications Prescribed to a Child
with Autism
Within the past 2 years, how many medications have been prescribed
to your child, specifically for Autism?

0-2
3-5
6-8
9 or more

Visually, it is seen that 0‐2 medications make up over half of the graph, with
3‐5 medications next and 9 or more medications representing the smallest amount.
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Table 5.2: The quantity of nonprescription medications used in a child with
autism
Within the past 2 years, how many NonPrescription medications has your child
taken?
Response
Percent

Response
Count

0‐2

76.9%

20

3‐5

11.5%

3

6‐8

0.0%

0

9 or more

11.5%

3

Answer Options

Answered question

26

Skipped question

0

Of the 26 participants who responded 76.9% (n=20) used 0‐2
nonprescription drugs. The percentage of those who used 3‐5 nonprescription
drugs was 11.5% (n=3). Those who used 6‐8 yielded 0% (n=0). Parents who used 9
or more were 11.5% (n=3).
Figure 5.2: The Quantity of Nonprescription Medications Used in a Child with
Autism
Within the past 2 years, how many NonPrescription medications has
your child taken?

0-2
3-5
6-8
9 or more
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Visually, over half of the parents use 0‐2 nonprescription medications, while
the next two portions are the same size with 3‐5 and 9 or more being utilized.
Construct 2: Prescription and Nonprescription Drugs and the Specific Ones
Used
Table 5.3: Prescription Medications Used By Children with Autism
Yes

No

Rating
Average

Response
Count

Risperdal (Risperidone)

4

19

1.83

23

Zyprexa

0

21

2.00

21

Geodon

1

20

1.95

21

Zoloft (Sertraline)

0

21

2.00

21

Adderall (Amphetamine)

3

19

1.86

22

Ritalin (Methylin)

3

20

1.87

23

Straterra

0

21

2.00

21

Concerta

2

20

1.91

22

Effexor (Venlafaxine)

0

21

2.00

21

Buspar (Buspirone)

0

20

2.00

20

Answer Options

Medications Not Listed Above

14
Answered question

26

Skipped question

0

Within the table, of the 26 respondents all responses were reviewed. The
response rate within the table gives an average rating regarding the yes and no
responses with yes equaling 1 and no equaling 2. The responses are then reported
as an average rating. Parents were also given the opportunity to list medications
not given as an option within the questionnaire.
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Of the 26 participants, a total of 23 responses were analyzed with (n=4)
using Risperdal and (n=19) not using the drug. The average rating was 1.83
meaning that more of the responses were closer to 2 representing a no response
value. Out of the 26 participants, 21 were analyzed as (n=0) used Zyprexa and
(n=21) not using the medication. This yielded a 2.00 average rating. The
participants who used Geodon were (n=1) with (n=20) not using the drug. With 21
parents responding, the average rating was 1.95. Of the 21 respondents, (n=0) did
not respond to using Zoloft and (n=21) reported not using Zoloft. The average
rating thus yielded 2.00. In regards to the use of Adderall, (n=3) used the
medication whereas (n=19) do not. The number of total respondents was (n=21)
with an average rating of 1.86. Those who utilized Ritalin were (n=3) while the
majority (n=20) did not use the drug. The total number of respondents to this drug
was (n=23). Straterra yielded (n=0) responses for using the drug while (n=21)
responded to not using the drug. The response count was (n=21) with a rating
average of 2.00.
The response count regarding Concerta yielded (n=22) as (n=2) stated that
they use Concerta versus (n=20) not using the drug. The rating average is 1.91. The
response count with Effexor was (n=21) with an average rating of 2.00 as (n=0) did
not respond to using the drug with (n=21) not using Effexor. Buspar yielded similar
results with (n=20) as a response count giving an average rating of 2.00. Those who
responded to using the drug was (n=0) while (n=20) do not use the drug. There
were (n=14) participants who responded that they used medications that were not
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listed. Those include Lexapro, Abilify, Vyvanse, Celexa, Prozac, Topamax, Lamictal,
Miralax, Trileptal, and Focalin.
Figure 5.3: Prescription Medications Used By Children with Autism
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Visually, the majority of the respondents (n=19) do not use prescription
medications. Those who do not use prescription medications visually represent the
shorter sections of the graph.
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Table 5.4: Nonprescription Medications Used by Children with Autism
Which Nonprescription medications, if any, has your child taken?
Yes

No

Rating
Average

Response
Count

Vitamin B6

3

22

1.88

25

Magnesium

5

20

1.80

25

Folic Acid

4

20

1.83

24

Calcium

4

20

1.83

24

Vitamin B3

3

21

1.88

24

Vitamin C

4

21

1.84

25

Zinc

3

20

1.87

23

Vitamin A

3

21

1.88

24

Ginkgo Biloba

1

23

1.96

24

Dimethylglycine

3

21

1.88

24

Answer Options

Non‐prescription medicine not listed above

13
Answered question

26

Skipped question

0

The total number of participants was 26 with all 26 responses recorded. If a
parent did not use any of the supplements listed within the questionnaire, they had
the ability to write in the ones they have given their child within a two‐year period.
The rating average reflects a 1 for a yes response and a 2 for a no response.
Vitamin B6 was used by (n=3) parents while (n=22) responded to not using
the supplement. This yielded a response count of (n=25) giving an average rating of
(n=1.88). Magnesium had a response count of (n=25) with (n=5) using the
supplement and (n=20) not using it. With folic acid (n=4) parents reported use of
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the supplement while (n=20) did not. This had a response count of (n=24) with an
average rating of (n=1.83). Parents’ response to calcium had a (n=24) response
count with (n=4) using the supplement while (n=20) did not. The rating average
was 1.83. Vitamin B3 yielded a response count of (n=24) with (n=3) stating that
they used the vitamin while (n=21) did not. The rating average was 1.88. A
response count of (n=25) represented vitamin C with (n=4) stating they used the
vitamin while (n=21) did not. The rating average was 1.84. Zinc, with a response
count of (n=23) had a rating average of 1.87 as (n=3) utilized the drug while (n=20)
did not. In regards to vitamin A, there was a response count of (n=24) with an
average rating of 1.88. The number of parents who use vitamin A was (n=3) while
(n=21) did not. Ginkgo biloba had a response count of (n=24) with an average
rating of 1.96. Those who used ginkgo biloba were (n=1) while (n=23) did not use
the herbal supplement. Dimethyglycine (DMG) had a response rate of (n=2) yielding
a rating average of 1.88. The number of those who stated they used the herbal
supplement was (n=3) and (n=21) who did not. There were (n=13) respondents
who listed other nonprescription drugs.. Some of the nonprescription drugs that
were used were a multivitamin, vitamin K, cod liver oil, medium chain triglycerides,
as well as trimethylglycine.
In construct two every parent reported use of at least one nonprescription
medication with their child. However, the responses indicated that non prescription
medication was not used by the majority of parents with their child.
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Figure 5.4: Nonprescription Medications Used By Children with Autism
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Visually, the majority of parents approximately (n=19) and up did not report
use of nonprescription medications for their child with autism. Those who do use
nonprescription drugs, represent the shorter bars.
Construct 3: Prescription and Nonprescription Side Effects
Table 5.5: Prescription Drug Side Effects
I have noticed side effects in the use of those medications?
Answer
Options

Strongly
Agree

Agree

Neutral

Disagree

Strongly
Disagree

Rating
Average

Response
Count

Nausea

0

0

13

2

8

3.78

23

Diarrhea

1

1

11

2

8

3.65

23

Increased
Appetite

4

1

13

0

7

3.20

25

Decreased
Appetite

2

4

12

1

5

3.13

24

Weight Gain

5

2

11

1

6

3.04

25

Weight Loss

0

1

14

3

5

3.52

23

Constipation

1

2

15

1

4

3.22

23

Answered question

56

26

When analyzing the rating average within the chart listed above, strongly
agree represents the value of 1, agree is 2, neutral is 3, disagree is 4, and strongly
disagree represents 5. Nausea yielded a response count of (n=23) with a rating
average of 3.78. Responses for strongly agree and agree were not stated, however, a
neutral response yielded the most responses with (n=13). There were (n=2)
responses for disagree and (n=8) for strongly disagree. Diarrhea had a response
count of (n=23) with an average rating of 3.78. Those who strongly agree and agree
were (n=1) while the majority responded as neutral (n=11). The next highest
response was (n=8) as strongly disagreed while only (n=2) disagreed. Those that
noticed an increased appetite were (n=25) with a rating average of 3.20. Those who
strongly agreed with the statement were (n=4) while only (n=1) agreed. The
majority of responses were neutral (n=13) with no one responding to disagree and
only (n=7) strong disagreeing. Those responding to a decreased appetite were
(n=24) with a rating average of 3.13. Those who strongly agreed were (n=2) with
(n=4) agreeing. The majority of respondents were neutral (n=12) while only (n=1)
disagreed with the rest of the respondents (n=5) stating they strongly disagreed
with noticing a decrease in appetite. In regard to weight gain, (n=25) was the
response count with an average rating of 3.04. Those who strongly agreed to
noticing weight gain were (n=5) with (n=2) agreeing. The majority of respondents
(n=11) were neutral with only (n=1) disagreeing and (n=6) strongly disagreeing to
noticing weight gain. Weight loss yielded a response count of (n=23) with a rating
average of 3.52. The majority of respondents (n=14) were neutral with their
response while no one responded to strongly agree there was (n=1) who agreed
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that weight loss was noted. Those who disagreed with the presence of weight loss
were (n=3) while those strongly disagreeing were (n=5). Constipation yielded a
response count of (n=23) with a rating average of 3.22. The majority answered
neutrally (n=15) with only (n=1) strongly agreeing and (n=2) agreeing to noticing
constipation. In regards to parents who disagree the number of respondents was
(n=1) while (n=4) strongly disagreed.
Figure 5.5: Prescription Drug Side Effects
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The figure above represents the side effects noted by parents when the child
with autism took prescription drugs, the majority of respondents, (n=11), felt that
the side effects were not an issue with their child as their response was neutral. The
next portion of the graph illustrates the response of strongly disagree while the rest
of the parents who utilized the nonprescription drugs did notice side effects.
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Table 5.6: Nonprescription Drug Side Effects
What side effects, if any, have you noticed in the use of NonPrescription medicine?
Answer
Options

Strongly
Agree

Agree

Neutral

Disagree

Strongly
Disagree

Rating
Average

Response
Count

Nausea

0

0

15

2

9

3.77

26

Diarrhea

0

1

13

1

10

3.80

25

Increased
Appetite

0

0

14

1

10

3.84

25

Decreased
Appetite

0

0

14

1

10

3.84

25

Weight
Gain

0

1

13

1

10

3.80

25

Weight
Loss

0

0

14

1

10

3.84

25

Answered question

26

Skipped question

0

Side effects pertaining to nonprescription drug use were analyzed. The rating
average is the same as the previous construct. Strongly agree is listed as a 1, agree
is a 2, neutral is 3, disagree is 4, and strongly disagree is 5. The table gives a rating
average for each of the side effects to show how close to one or other end of the
Likert scale the reporting fell. For example, the rating average for nausea is
concentrated.
Nausea in nonprescription drug use had a response count of (n=26) yielding
a rating average of 3.77. There were no responses to strongly agree or agree. The
majority of the responses fell under neutral (n=15) with only (n=2) disagreeing and
(n=9) strongly in disagreement. Diarrhea had a response count of (n=25) with a
rating average of 3.80. No one responded with strongly agree and only (n=1) agreed
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that diarrhea was a side effect. The majority (n=13) were neutral while only (n=1)
disagreed with (n=10) strongly disagreeing. Increased appetite had a response
count of (n=25) with an average rating of 3.84. No one responded to strongly agree
or agree, however, the majority (n=14) responded to neutral. Only (n=1) disagreed
that their child’s appetite decreased with the use of the medication and (n=10)
strongly disagreed. Those who reported noticing a decrease in appetite were
(n=25) which yielded an average rating of 3.84. None of the respondents strongly
agreed or agreed that there was decreased appetite. The majority (n=14) were
neutral in their response with only (n=1) disagreeing and (n=10) strongly
disagreeing.
Weight gain in relation to nonprescription drug use had a response count of
(n=25) with a rating average of 3.80. No one responded to strongly agree while only
(n=1) responded with agree. The majority of respondents (n=13) were neutral
while (n=1) disagreed and (n=10) strongly disagreed. Weight loss yielded a
response count of (n=25) with a rating average of 3.84. There were no responses to
strongly agree or agree. The majority of participants (n=14) were neutral while
only (n=1) disagreed and (n=10) strongly disagreed.
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Figure 5.6: Nonprescription Drug Side Effects

Side Effects of Nonprescription Drugs
16
14

Parent Responses

12
Strongly Agree

10

Agree

8

Neutral
Disagree

6

Strongly Disagree
4
2
0
Nausea

Diarrhea

Increased
Appetite

Decreased
Appetite

Weight Gain

Weight Loss

Side Effects

The figure above shows the majority of parents responded neutrally when
noticing side effects of nonprescription drugs. Those who strongly disagreed had
the next highest levels. The smallest bars on the graph represent those who
strongly agreed or agreed.
Table 5.7: Weight Gain in Prescription Drug Use
If there was weight gain, approximately how many pounds were gained within a
year of its use?
Response
Percent

Response
Count

0‐3

57.1%

12

4‐6

14.3%

3

7‐9

9.5%

2

over 10

19.0%

4

Answer Options

61

Answered question

21

Skipped question

5

In table 3c, in the range 0‐3 pounds, 57% of the respondents reported weight
gain in the child (n=12). In the range of 4‐6 pounds, 14.3% (n=3) noticed weight
gain. Those who reported seeing a weight gain of 7‐9 pounds were 9.5% (n=2). A
weight gain of over 10 pounds was seen by 19% (n=4). The data show weight gain
was experienced in every category across prescription drug use.
Construct 4: Prescription and Nonprescription Change in Nutritional Status
Table 5.8: Changes in Nutritional Status with Prescription Medication
I have noticed a change in my child's nutrition due to the use of prescription
medication.
Response
Percent

Response
Count

Strongly Agree

3.8%

1

Agree

19.2%

5

Neutral

46.2%

12

Disagree

19.2%

5

Strongly Disagree

11.5%

3

Answer Options

What were the changes you noticed?

8

62

Answered question

26

Skipped question

0

Regarding nutritional status in prescription drug use, 3.8% strongly agreed
to noticing a change (n=1). Those who agreed were 19.2% (n=5). Those who
disagreed were 19.2% (n=5) and those who strongly disagreed were 11.5% (n=3).
The majority of parents were neutral with 46.2% (n=12). The questionnaire
contained a section in which parents were to report specifically the changes that
they noticed. The responses varied and included that the child had fewer
meltdowns, stopped hitting others, and became calmer. Other responses included
weight gain, poor eating habits, starving all the time, greater appetite, altered food
taste, and eating less as behaviors parents felt were induced by medications.
Figure 5.7: Changes in Nutritional Status with Prescription Medication
I have noticed a change in my child's nutrition due to the use of
prescription medication.

Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
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Less than half of the respondents felt neutral when viewing the nutritional
status in the utilization of prescription medication. Those respondents who agreed
and disagreed were very similar in size, whereas, those who strongly agreed that
they saw changes in nutritional status represented the smallest portion of the pie
chart.
Table 5.9: Changes in Nutritional Status with Nonprescription Medication
I have noticed a change in my child's nutrition status due to the use of Non
Prescription medication.
Response
Percent

Response
Count

Strongly Agree

7.7%

2

Agree

0.0%

0

Neutral

53.8%

14

Disagree

7.7%

2

Strongly Disagree

30.8%

8

Answer Options

What changes were noticed specifically, if any?

3
Answered question

26

Skipped question

0

In the table, when viewing a change in nutritional status in nonprescription
drug use, 7.7% strongly agreed (n=2). There were no respondents within the agree
category. The majority of the responses fell within neutral at 53.8% at (n=14).
Those who disagreed resulted in 7.7% (n=2) while 30.8% strongly disagreed (n=8).
There were (n=3) who noted specific changes. The changes noticed specific to the
nutritional status and medication were similar to those mentioned previously and
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included fewer outbursts, increased appetite, poor eating habits, hungry all the time,
altered food taste, as well as eating less.
Figure 5.8: Changes in Nutritional Status in Nonprescription Medications
I have noticed a change in my child's nutrition status due to the use
of Non-Prescription medication.

Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree

Approximately half of the parents were neutral regarding nutritional status
in nonprescription medication use. The next largest portion consisted of responses
within the category of strongly disagree. Those who disagreed as well as strongly
agreed had similar feelings as depicted by the portions in the chart.
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Construct 5: Source of Information for Prescription and Nonprescription
Table 5.10: Nonprescription Medicine Recommended by Outside Family
Members
The NonPrescription medicine was recommended by someone outside of the
family.
Response
Percent

Response
Count

Strongly Agree

0.0%

0

Agree

23.1%

6

Neutral

53.8%

14

Disagree

11.5%

3

Strongly Disagree

11.5%

3

Answer Options

Who recommended the non‐prescription medication or how did you
find out about it?

5

Answered question

26

Skipped question

0

The table indicates that of the 26 respondents, no one strongly agreed to
receiving recommendations outside of the family. Those who agreeD to the
question were 23.1% (n=6). The majority of parents were neutral, 53% (n=14).
Those who disagreed and strongly disagreed answered the same at 11.5% (n=3).
The option to respond as to who recommended the medication was given. Parents
stated that recommendations were given by DAN! doctors, autism literature, the
Internet, as well as Yahoo! groups.
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Figure 5.9: Nonprescription Medicine Recommended by Outside Family
Members
The NonPrescription medicine was recommended by someone
outside of the family.
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Slightly over half of the respondents were neutral in relation to the
recommendation of nonprescription medicine from members outside of the family.
The next largest portion was in agreement that they received recommendations
from someone outside of the family outside of the family. Those who disagreed and
strongly disagreed were similar in the volume of the response.
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Figure 5.10: Discussion of Over the Counter Medicines with Primary Care
Physician
I always discuss all over the counter medicines with the primary
physician before administering them to my child.

Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree

The chart shows that a majority of parents discussed all over the counter
medicine with their primary care physician. The next portion shows that they also
discussed all medication use with their physician. There is also a large portion who
feel neutral regarding the question and the smaller portions of the pie chart do not
discuss all over the counter medicines. Based on the chart representation more
families agreed that they discussed over the counter medications with their doctor.
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Figure 5.11: Information Gathered on the Internet Related to Medicine and
Autism
What percentage of information has been gathered on the internet
in relation to medicine and Autism?

0-20%
21-40%
41-60%
61-80%
81-100%

Visually, approximately 0‐20% utilized the Internet as a source when
gathering data about medicine and what to give their child. The next portion that
was rather large in size was the neutral category at 41‐60%. Those who used the
Internet 81‐100% of the time were next as the smallest portions and represented
61‐80% and 21‐40%.
Nutritional Intake & 24Hour Recalls
The 24‐hour recalls were collected from parents who have a child with
autism and were analyzed for significance at a p‐value of <0.001. The recommended
dietary allowances and recommended intakes were viewed in relation to the intake
of a child with autism versus a typical child. A child could have fallen within three
categories, either below the recommended intake, recommended intake, or above
the recommended intake. The children were categorized either as a typical child or
a child with autism. A total of 13 participants were used. Two of the children were
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disregarded as they fell above the age parameters of the RDA & AI used within the
USDA study. Typical children were matched from the USDA nutritional intake
survey conducted in 2005‐2006, which was categorized by age and gender. The
results were utilized in the comparison of children with autism and the
recommended dietary intakes. The micronutrients were selected based on the
literature, which reports these micronutrients as ones more likely to be deficient in
children with autism.
Originally, age was analyzed for significance, however, when analyzing age
and nutrients, all p‐values were the same at all levels indicating that children were
eating some of the same foods in a given day. Therefore, all nutrients were averaged
in order to compare the data effectively allowing for status and nutrients to be
analyzed.
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Table 5.11: Comparison of Nutritional Allowances of Typical Children versus
Children with Autism in Males Ages 211
(n=13)
RDA & AI

Typical Child with
Child
Autism

p‐value:
status &
nutrients

Vitamin A

300 µ/day

624

589.89

‐‐‐

Vitamin B 6

0.5 mg/day

1.63

1.92

‐‐‐

Vitamin C

15 mg/day

81.8

82.69

‐‐‐

Calcium

500 mg/day

2034

1092

‐‐‐

Iron

7 mg/day

14.2

17.57

‐‐‐

Magnesium

80 mg/day

221.5

279.1

‐‐‐

Vitamin B 12

0.9 µ /day

1.21

3.24

‐‐‐

Folate

150 µ /day

141.5

278.1

0.157

Mg = milligrams
µ = micrograms
RDA = recommended dietary allowance
‐‐‐ Nutrients are considered a constant

AI = adequate intake

Significance was analyzed at a p‐value of 0.001; however, the only nutrient
that yielded a p‐value was folate at 0.157 demonstrating no significance. The other
nutrients yielded a constant, which appears as no change across nutrient intake.
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Chapter 6: Discussion
Construct 1: Prescription vs. nonprescription drugs and number used
The results indicate that within the past two years, the majority of parents
used 0‐2 drugs, both prescription and nonprescription. It seems as though many
families utilized CAM, however, they tried a smaller amount than reported in a 2004
dissertation by Hires at the University of Kentucky. It was expected that
complementary and alternative medicine would be utilized more; however, only
three participants had utilized nine or more CAM. Many families have been known
to try a variety of drugs and supplements in treating a child with autism. At the time
of the study families might have been reducing their exploration of specific CAM.
The research demonstrated that approximately 92 percent of parents used CAM
therapies on their child with ASD (5), which was different to the result found in this
study. However, on that construct everyone reported using at least one prescription
or nonprescription medication. When majorities of families are trying nine or more
different drugs, there should be cause for concern, especially if those drugs are not
discussed with a physician.
The hypothesis (H1) tested if parents used complementary and alternative
medicine more than prescription drugs in the treatment of a child with autism. The
hypothesis was rejected as the utilization of CAM, specifically when three or more
drugs were used, only 23 percent of families stated they used CAM. In the use of
prescription medication, only 26.9 percent of parents stated they used the
medication, specifically when three or more were used.
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Construct 2: Prescription and nonprescription drugs and the specific ones
used
Since the majority of participants were using only 0‐2 drugs in treating their
child’s symptoms, the types of drugs used were limited and few. However, when
prescription drugs were examined, the majority of children were taking Risperidal.
This drug is the most widely used drug for children with autism to treat symptoms
such as aggression, irritability, and self‐injury (51). There are also many other
options besides the ones listed in which parents admitted that their child took.
Some of these drugs are used for constipation, depression, as well as anxiety.
There appeared to be a wider range of use in complementary and alternative
medicines. Those that were used varied across the board with magnesium, folic
acid, calcium, and vitamin C being the most utilized. This agrees with other studies
that reported CAM use (29) However, vitamin B 6 , vitamin B 3 , zinc, and DMG were
not too far behind. The extent of how the child has changed from starting the CAM is
unclear, because parents using CAM do not obtain blood levels of the micronutrients
used to see if their child is truly deficient and needs the supplemental vitamins and
minerals and record keeping about behaviors pre and post CAM are sporadic and
anecdotal.
Parents should also be mindful of what the child eats on a regular basis and
work with a dietitian who can aid the child in trying new things. This will also be an
important time to discuss with the dietitian the role vitamins and minerals have on
the body. Many B vitamins, for instance, are water‐soluble, meaning that the body
utilizes what it needs and then excretes the rest. There are doctors who are telling
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parents to take these supplements whether in pill or cream form without knowing a
child’s deficiency levels or telling the parent how it is utilized in the body,
reiterating why it is important to discuss nutritional related material with a
dietitian.
Construct 3: Prescription and nonprescription side effects
Side effects affect every medication available. Complementary and
alternative medicine does not have a notable effect because there is no research
evidence to confirm a dose response. Therefore, the reported side effects were
minimal when analyzing parent’s responses. The majority of parents, regarding the
side effects in prescription drug use stated they felt neutral or strongly disagreed.
The response regarding weight gain was analyzed as many of the
prescription drugs taken by children with autism caused increased appetite, leading
to increased weight. However, the responses were split as five strongly agreed
versus six who strongly disagreed. This could be due to the child’s pattern and
behavior during mealtime or parents positive or negative denial of the value of
these drugs when treating autism symptoms. Some children with autism will only
eat five foods in a given day versus a child who will eat just about anything or have
more of a craving for fast food chicken nuggets and French fries. Therefore, weight
gain and increased appetite can be seen in some children, but not necessarily all and
this goes back to their original eating patterns and behaviors, which were not
assessed.
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The amount of weight gain noticed was asked of parents in an effort to see
just how many pounds were added. The majority of parents listed 0‐3 pounds
(n=12), whereas the remaining families (n=9) listed an increase in weight beginning
at 4 pounds or more. Other studies compared specific weight gain in children on
psychoactive drugs and reported higher weight gain numbers than this current
study (57). The 0‐3 pound range would be expected to be high, as some families
may not have seen a gain due to their child not taking the drugs that impact weight
gain. Knowing that children suffer from potential weight gain, information on how
to cope with the side effects should be given. Seeking out a nutritionist can have
added benefit to the child as suggestions can be made on what to feed a child who
feels as though they are starving.
The hypothesis (H2) tested if over half of the parents will note a weight gain
of four pounds or more in their child in relation to prescription drug use. The
hypothesis was rejected as 57.1 percent of parents noted a weight gain of 0‐3
pounds, whereas only 42.8 percent noted a weight gain of four pounds and over.
Despite this result it is clear that weight gain remains an issue in care of the child
with autism who is prescribed psychoactive medications.
Construct 4: Prescription and nonprescription change in nutritional status
A small number of families felt that the use of the prescription medication
changed their child’s nutritional status (n=6). These results held true as
approximately the same amount had noticed an increase in weight (n=5). The
majority of parents did not notice a change in nutritional status regarding the intake
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of prescription and nonprescription drugs, a change in nutritional status. A change
in nutritional status pertaining to CAM occur naturally in the foods that we eat,
however, if a child was deficient, a change in nutritional status should be noted. The
results demonstrated that the children with autism do not necessarily have a
deficiency as the research demonstrated which is contrary to the report from
Rimland who found recommends doses of various nutrients in relation to children
with autism.
Construct 5: Prescription and nonprescription source of information
The results regarding who recommended nonprescription medicine,
specifically by someone outside of the family was noted. The responses were split
as six parents had taken advice from a non‐family member while six stated that they
did not. The majority of the parents did speak with their physician (n=15), while
less than that did not speak with their physician (n=5). Within this study, the
results contraindicated what typically occurs in parents when they are trying
various methods of treatment as much of the research states that a doctor is not
consulted. There is a possibility that more and more parents are taking advice to
speak with a healthcare professional, knowing the various consequences that exist
or in the case of families working on autism they consider the DAN doctor who may
be the one prescribing the CAM as the consulting doctor and not their family doctor.
This would be a limitation in the questionnaire development where the question
could have been stated to exclude the DAN doctor as the physician to whom the
CAM was reported.
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The majority of parents are using the Internet at least 20 percent of the time
(n=11), however, 15 percent obtain almost all of their information from the internet.
It causes concern as to what website the parent is visiting and what the source of
the information he or she is reading. Parents are able to access all levels of quality
regarding the Internet. Therefore, it is vital that parents research reputable sites.
The hypothesis (H3) tested if more than half of the parents will utilize the Internet
as their only source of information when researching various drugs both
prescription and nonprescription. The hypothesis was accepted because a greater
percentage of parents used the Internet as their only source (0‐20 percent) and as
their chief source of information (57.7 percent).
Nutritional Intake and 24Hour Recalls
The 24‐hour recalls were utilized in an effort to see whether children with
autism demonstrated a deficiency regarding certain vitamins and minerals.
Although, this does not test a deficiency as a whole, it does look at a day’s intake to
see if there is any correlation. The results were then tested against a typical child as
well as the recommended dietary allowances. As a whole, the majority of children
with autism did not demonstrate a deficiency in the foods eaten.
The majority of the responses yielded constants meaning that the
relationships remained the same at either level of status in relation to the intake of
nutrients. However, it is noted that a typical child did not meet the recommended
dietary allowances of folate, whereas a child with autism did. Most children with
autism are on a gluten‐free/casein‐free diet, which limits what they eat. Folate is
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found within green leafy vegetables and is a food group that can be resourceful if on
a GFCF diet. The typical child, however, is more than likely not on a GFCF diet unless
they have Celiac’s disease. This will allow for more options when deciding what to
eat.
The hypotheses (H4) tested if children with autism will demonstrate a
deficiency in vitamin B 6 , magnesium, calcium, and vitamin B 12 when compared to
the typical child. The hypothesis was rejected as it was found that a child with
autism receives above normal levels of the specific nutrients studied. However, the
typical child had lower levels of folate in the diet.
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Chapter 7: Limitations
Several limitations are to be noted within the study. The first involves the
sample size. Although this was a decent sample size to work with, some potential
error could have been eliminated if more parents had participated. However,
sometimes having a child with autism can be time consuming, which is a potential
reason for not participating. A larger sample would have been good when working
with the 24‐hour recalls. When separating the recalls based on age, the sample for
each range became smaller not allowing us to toss out participants who may have
had a substantially higher or lower amount of certain nutrients. When one child had
a large intake of magnesium for example and another has a small intake, the results
can be skewed. It would have been better if the highs and lows were taken out to
obtain more accurate results, however, the sample size did not allow for that.
The sample population could have been larger as well. The medication
questionnaire was distributed via a total of three listservs, however, a response of
only 26 was collected. Many of the listservs included members of approximately
100‐200 families. The question arises of why there were very few responses
knowing the total amount of members? Reasoning could lead one to the belief that
there is a population that feels nutrition is an important component in the life of a
child with autism. Therefore, the family member wishes to aid those involved in the
study to find more research regarding the topic. There are also those who simply
did not make the time, although there may have been conscious efforts to reply. The
selection bias might have skewed the reporting of CAM because more parents who
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do not believe in CAM use might have chosen to participate. Whatever the selection
bias if this occurred, it can be expected that a larger number of families would have
generated more diverse results across the prescription and non‐prescription use
construct.
In addition, 24‐hour recalls only provide what the intake was for that child
on a specific day, regardless of the situation. It may not demonstrate a typical day
where the family may have been pressed for time and had to go through a fast food
drive‐thru or mom did not have enough time to cook when she cooks six out of the
seven nights a week. In order to have even more specific results regarding typical
intake, the researcher could use food frequency questionnaires that list in great
detail how often a person eats certain foods from the food guide pyramid in a given
month.
The survey did not allow for a “non‐applicable” response for parents who do
not utilize prescription or nonprescription drugs. Therefore, the response labeled
“neutral” was used. All of these factors could have enabled greater significance,
however, when replicating the process an individual can take into consideration all
of the limitations.
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Another limitation was in regard to the 24‐hour recalls. Originally, age was
to be a factor when analyzing the data; however, it was found that when analyzing
age all the p‐values were the same on all levels. This could possibly be due to the
children ingesting most of the same foods. The sample size could also play a role in
which a larger sample could have yielded greater results. When reviewing the diets,
only one child was on a GFCF diet, allowing for the remaining children to have more
flexibility with their food choices.
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Chapter 8: Conclusions and Recommendations
The need for creating educational material for not only healthcare
professionals but parents is great regarding information on nutritional
supplementation. The supplements and their side effects pose complications that
must be considered when assigning prescription medication to children with
autism. Prescription and nonprescription drug use influence the nutritional status
of a child with autism, specifically the implication of weight gain. Laboratory
analyses from children with autism have shown high excretion and deficiency rates
for certain vitamins and minerals. The healthcare provider should include these
observations in the assessments that are used to determine the protocol of care for
medical nutrition therapy.
There are varying treatment options available that aid in managing the
behavioral symptoms of autism. A major concern is the source of information that
parents use. In addition, is the family reporting to their doctor the over‐the‐counter
treatments being used on their child? Some of the CAM used has been understudied
and claims have been made for treatments that help control behavioral symptoms.
These treatments are not evidence based but anecdotal information proliferates on
the Internet and among parent support groups.
The objectives of this study were fourfold with the first assessing the
nutritional intake of children with autism in comparison to the typical child. It was
found when analyzing 24‐hour recalls all of the nutrients, except folate, gave a p‐
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value of 0.157, which has no significance. All other nutrients were considered
constant when analyzed meaning that nothing changed in relation to the responses.
The second objective was to examine the means by which parents collected
their data regarding prescription and nonprescription drugs. The data did show
that parents utilized the internet, but it could not be determined to what extent and
which websites were viewed in an effort to gather information. Approximately, 15
percent used the internet 81‐100 percent of the time when gathering information on
autism and medicine. Again, the content and quality of the sites were not discussed
and if replicating the study, a researcher should find out the specific websites being
utilized. Therefore, in this study less than half of the parents utilize the internet as
their only resource when researching medicine and autism.
The third objective was to examine the extent to which parents use
complementary and alternative medicine as an intervention. It was found that
parents used the same amount of CAM as they did prescription alternatives, as they
answered another research question. However, some parents did utilize nine or
more CAM, showing that the use of CAM is fairly extensive but not as widespread as
previous studies suggest (5). Further research studies are needed to gather data
from a larger group of parents who have children with autism to confirm the extent
of CAM usage.
A fourth objective was to examine weight gain. Many children with autism
have succumbed to increases in weight due to the side effects of atypical
antipsychotics. It was found that the majority of children taking prescription
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medications included Risperidal, an atypical antipsychotic that causes increased
appetite leading to weight gain. However, how substantial was the weight gain?
Most of the parents noted a weight gain in the range of 0‐3 pounds with less than
half noting a 4‐pound or more weight gain. This was dependent on the types of
medications that were utilized as not all parents were giving their children atypical
antipsychotics. Also, if the children were also on disordered eating patterns the
weight gain may have been seen as beneficial and not an issue.
These findings demonstrate that more work is to be done when reviewing
the types of drugs prescribed to address symptoms in a child with autism. Parents
should be mindful of all alternative therapies but use outside sources and references
with caution as they will find that some sources are not as reliable as others. The
role that nutrition plays in a child with autism is important. The research data
showed deficiencies in a number of vitamins and minerals. If parents can be
educated on the foods that have nutrient value for their children’s diet minus the
supplementation, children will be able to utilize those nutrients more effectively
than using a pill. Dietitians hold the key to feeding a child that may have food
aversions as well as teaching parents how to implement a variety of foods into the
family diet. Combating the side effects of atypical antipsychotics and nutrient
medication interactions can also be of value when discussed with a dietitian.
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Nutrition can be of great assistance to parents who have a child with autism,
as there are some vitamins and minerals that aid in neurological development. It is
vital to find out which nutrients a child is deficient in before supplementation. It is
also important to try to utilize foods that naturally contain the vitamins and
minerals. Through more research and in cooperation with parents who have
children with autism, healthcare professionals may be able to find one more the link
in the puzzle of autism.
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Appendices:

Prescription and Complementary and Alternative Medication Questionnaire
Dear Participant:
The Department of Nutrition and Food Science at the University of Kentucky has
developed a survey instrument to gather information regarding the use of prescription and
non-prescription medication in regards to children with autism spectrum disorders. This
information will then be compared to the nutritional status of children with autism versus
typical children. After reviewing the information provided, please answer the questions
to the best of your ability. It will take no more than 15 minutes to complete the
questionnaire. If you are unaware of all of the medications that your child takes, it is
advised that you have them with you in order to complete the survey accurately.
To the best of our knowledge, there are no risks or harm associated with this study. Your
responses, in combination with those of other participants, will help us understand how
prescription and non-prescription medications affect the nutritional status of children with
autism.
Your responses will be kept confidential and will only be used for this study. As
indicated above, your information will be combined and reported with responses from
other participants taking part in the study.
If you decide to take part in the study, it should be because you really want to volunteer.
Your participation in this study is voluntary and you may decline to participate.
If you have any questions about the study or the procedures, you may contact the primary
researcher, Dr. Hazel Forsythe, via email (nfshazel@email.uky.edu) or call (859-2574146). In addition, if you have any questions about your rights as a volunteer in this
research, contact the staff in the Office of Integrity at the University of Kentucky at
859-257-9428 or toll free at 1-866-400-9428. If you agree to participate, please begin the
survey.
Thank you for your participation.
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1. Within the past 2 years, how many medications have been prescribed to
you child, specifically for autism?
a. 0-2
b. 3-5
c. 6-8
d. 9 or more
2. What are the names of the medications used by your child in regard to
question number one?
Yes

No

Risperdal
Zyprexa
Geodon
Zoloft
Adderall
Ritalin
Straterra
Concerta
Effexor
Buspar
Medications not listed above

3. I have noticed side effects in the use of those medications?

Strongly Agree
Agree
Nausea
Diarrhea
Increased
Appetite
Decreased
Appetite
Weight Gain
Weight Loss
Constipation
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Neutral Disagree Strongly
Disagree

4. If there was a weight gain, approximately how many pounds were gained
within a year of its use?
a. 0-3
b. 4-6
c. 7-9
d. Over 10
5. I have noticed a change in my child’s nutrition due to the use of
prescription medication.
a. Strongly agree
b. Agree
c. Neutral
d. Disagree
e. Strongly Disagree
What were the changes you noticed?
________________________________________________________

6. The prescription medication has been effective with my child.
a. Strongly Agree
b. Agree
c. Neutral
d. Disagree
e. Strongly Disagree
How do you feel it was effective? How do you feel it was ineffective?

7. Within the past 2 years, how many non-prescription medications has your
child taken?
a. 0-2
b. 3-5
c. 6-8
d. 9 or more
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8. Which non-prescription medications, if any, has your child taken?
Yes

No

Vitamin B6
Magnesium
Folic Acid
Calcium
Vitamin B3
Vitamin C
Zinc
Vitamin A
Ginkgo Biloba
Dimethylglycine
Non-prescription medicine not listed above

9. The non-prescription medicine was recommended by someone outside of
the family
a. Strongly agree
b. Agree
c. Neutral
d. Disagree
e. Strongly disagree
Who recommended the non-prescription medication or how did you find
out about it?
__________________________________________________________
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10. What side effects, if any, have you noticed in the use of non-prescription
medicine?

Strongly Agree
Agree

Neutral

Disagree

Strongly
Disagree

Nausea
Diarrhea
Increased
Appetite
Decreased
Appetite
Weight Gain
Weight Loss

11. I have noticed a change in my child’s nutrition status due to the use of
non-prescription medication.
a. Strongly agree
b. Agree
c. Neutral
d. Disagree
e. Strongly Disagree
What changes have you noticed, specifically, if any?

12. The non-prescription medicine has been effective with my child
a. Strongly agree
b. Agree
c. Neutral
d. Disagree
e. Strongly disagree
What changes were noticed, specifically, if any?
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13. I always discuss all over the counter medicines with the primary physician
before administering them to my child.
a. Strongly agree
b. Agree
c. Neutral
d. Disagree
e. Strongly disagree
14. What percentage of information has been gathered on the Internet in
relation to medicine and autism?
a. 0-20%
b. 21-40%
c. 41-60%
d. 61-80%
e. 81-100%
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